Scandinavian ChemoTech AB prepares for expansion and recruits a Chief Operating Officer
ChemoTech signed an agreement today with Urban Widén, whom on a consulting basis will join as the company's Chief Operating Officer. This is a strategic role where he alongside the CEO and founder Mohan Frick will take the company in a new and exciting phase.
Urban Widén is a very experienced strategist in life science with an impressive experience from the commercial side for example as a subsidiary manager within AstraZeneca. Urban also has experience from both operational roles and board roles in entrepreneurial companies, which contributes with further important experiences for Scandinavian ChemoTech.
Most recently, Urban came from a position as acting CEO of Lumito AB (publ), where he took over as CEO with a short notice. An assignment that was shown drive and commitment.
“Now that Scandinavian ChemoTech is planning for a new expansive phase and rapid growth Urban is to be an important reinforcement of the management team. I warmly welcome Urban to the team "- says the Company's CEO Mohan Frick.
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 29-03-2021 08:30 CET.
For more information, please contact:
Mohan Frick, CEO
Phone: +46 (0)10-218 93 00
Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail: certifiedadviser@penser.se
Scandinavian ChemoTech AB (publ)
ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer patients access to a new treatment alternative, Tumour Specific Electroporation™ (TSE), available for treatment of both humans and animals. There are a large number of cancer patients whose tumours for various reasons cannot be treated by conventional methods but where TSE can be a solution. Therefore, the company continuously evaluates new opportunities and areas of application for the technology. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Erik Penser Bank is the company's Certified Adviser. Read more at: www.chemotech.se.
